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Pts with PAD
(n¼239 Lesions)
Pts without PAD
(n¼2207 Lesions) p-value
Diabetes 43.9% 27.3% <0.0001
History of CABG 26.5% 9.8% <0.0001
Stable ischemic heart
disease
50.5% 40.5% 0.0069
Creatinine clearance
<60 mL/min
23.0% 15.2% 0.005
Rotablator use 8.9% 3.0% <0.001
Total stent length, mm 28.9 [26.6, 31.2] 28.1 [27.3, 28.8] 0.49
Minimum stent area,
mm2
6.0 [5.7, 6.3] 6.2 [6.1, 6.3] 0.17
Proximal reference
calcium arc, 
85 [70, 100] 75 [72, 79] 0.20
Proximal stent edge
dissection
4.5% 3.0% 0.32
Distal reference plaque
burden, %
43.3 [41.2, 45.3] 41.7 [41.0, 42.3] 0.14
Distal reference
calcium arc, 
89 [73, 106] 73 [68, 77] 0.055
Distal stent edge
dissection
7.5% 3.7% 0.0067
TLR at 2 years 6.6% 2.9% 0.0066
MACE 8.9% 7.6% 0.0030
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMTCT-347
Assessment of Intravascular Ultrasound-derived Minimal Lumen Area and
Fractional Flow Reserve to Evaluate Functionally Signiﬁcant Coronary Artery
Disease: A Meta-Analysis
Jae-Sik Jang1, Yeo-Jeong Song2, Han-Young Jin2, Jeong-Sook Seo2, Tae-Hyun Yang2,
Dae-Kyeong Kim2, Dong-Soo Kim2
1Saint Luke’s Mid America Heart Institute, Kansas City, MO, 2Inje University Busan
Paik Hospital, Busan, Korea
Background: There have been many studies that investigated best cut-off values of
intravascular ultrasound minimal lumen area (MLA) to predict the functional signiﬁ-
cance of stenosis. We conducted a systematic review and meta-analysis to evaluate
diagnostic performance and accuracy of IVUS-MLA to predict functionally signiﬁcant
non-left main coronary artery disease as demonstrated by fractional ﬂow reserve (FFR).
Methods: We searched MEDLINE, EMBASE, and Cochrane databases for studies
comparing IVUS and FFR to show the best MLA cut-off values predicting signiﬁcant
non-left main coronary artery stenosis. The Quality Assessment of Diagnostic Ac-
curacy Studies list was used to assess included study quality. Quantitative data syn-
thesis was accomplished through random-effects meta-analysis, and heterogeneity was
assessed with the I2 test.
Results: Fifteen studies were included enrolling 3,428 patients with 3,775 lesions.
The weighted overall mean MLA cut-off value was 2.59 mm2. The pooled sensitivity
of MLA predicting functionally signiﬁcant coronary stenosis was 0.73 (conﬁdence
interval [CI] 0.70 to 0.75) and speciﬁcity was 0.66 (CI 0.64 to 0.68). Positive like-
lihood ratio (LR) was 2.30 (CI 2.01 to 2.62) and LR (-) was 0.35 (CI 0.27 to 0.45).
The pooled diagnostic odds ratio was 7.21 (CI 4.87 to 10.67) and the area under the
receiver operator curve for all the trials was 0.778 with the Q point (Q*) of 0.717.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/ImConclusions: IVUS-derived MLA cut-off value could be a useful tool to exclude
functionally insigniﬁcant non-left main coronary artery disease.
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Background: Contrast induced nephropathy (CIN) is serious problem of percuta-
neous coronary interventions (PCI). An excessive amount of contrast dye is main
cause of CIN for chronic kidney disease (CKD) patients. Therefore, IVUS guided
minimum contrast PCI (MCPCI) that is performed with IVUS guidance throughout
the procedure using minimum amount of contrast dye, might reduce the risk of CIN.
The aim of this study was to clarify the safety and efﬁcacy of MC-PCI for CKD
patients.
Methods: From January 2008 to March 2014, 60 patients with 80 lesions which
serum-Cr level (SCr) S1.5mg/dl and treated by IVUS guided MC-PCI were
enrolled in this study and analyzed retrospectively. All procedures were planned
based on diagnostic CAG and performed electively after several days. Hemodialysis
patients and CTO lesions were excluded. IVUS guided MCPCI was performed as
follows. First, operator manipulated guidewire without contrast injection referring
the previous angiogram image and then examined by IVUS. After that, stent im-
plantation and post dilatation is performed according to IVUS ﬁndings alone. At the
end of index procedure, minimal amount of contrast dye was injected through the
aspiration catheter to conﬁrm coronary ﬂow and absence of vessel perforation.
CIN is deﬁned as elevation of SCr level is equal and more than 0.5mg/dl within
48 hours.
Results: Mean used contrast dose at PCI was 13.28.9 ml and that was signiﬁcantly
lower than mean contrast dose at diagnostic CAG ( 3826.4ml; P< 0.0001). One case
was treated with contrast free procedure. SCr level of 48 hrs after procedure was
signiﬁcantly lower than that of pre procedure (2.10.6 mg/dl vs 2.00.7 mg/dl;
P¼0.007). Only 2 cases (3%) were complicated CIN after index procedure. There was
no complication of death and Q wave myocardial infarction during hospitalization.
Conclusions: IVUS guided MCPCI is safe and feasible procedure for CKD patients to
reduce the risk of CIN.
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Background: It has been reported that intensive lipid lowering therapy can induce
regression of coronary atherosclerosis in patients with stable coronary artery disease.
However, direct evidence comparing the impact of intensive and moderate lipid
lowering therapy on the plaque behavior in patients with ACS is lacking. The aim of
this study was to compare these therapies on the regression of coronary atherosclerosis
in patients with ACS by using intravascular ultrasound (IVUS).
Methods: A total of 118 patients with ACS who underwent IVUS interrogation before
percutaneous coronary intervention (PCI) and found to have mild to moderate non-
culprit plaques, were randomly assigned to intensive (pitavastatin 4mg/day (n¼29) or
atorvastatin 20mg/day (n¼30)) or moderate (pravastatin 10mg/day (n¼30) or ﬂu-
vastatin 30mg/day (n¼29)) lipid lowering therapy. Study protocol included IVUS
examination at baseline and at 10-month follow up. The target plaque had to be a
minor lesion (< 50% diameter stenosis) and located at least 5 mm apart from any PCI
site. IVUS images were evaluated at an interval of 1 mm for 10 mm length in each
plaque.
Results: Intensive therapy induced regression of coronary atherosclerosis, whereas
moderate therapy allowed insigniﬁcant progression (-9.0% vs 1.5%, p¼0.001). The
analysis in whole patients indicated that percent change in plaque volume was
correlated with LDL-C value at 10-month follow-up (R¼0.220, p¼0.02), but not with
the percent change LDL-C value (R¼0.172, p¼0.08). 38 patients had plaque pro-
gression and 64 patients had plaque regression. Multivariate analysis revealed that
intensive lipid-lowering therapy (p< 0.01) and EEM volume at baseline (p¼0.04)
were associated with the presence of plaque regression, whereas no association was
observed between LDL-C value at 10-month follow-up and plaque regression
(p¼0.57).
Conclusions: Intensive lipid lowering therapy induced regression of coronary plaque
compared with moderate lipid lowering therapy in patients with ACS. Our results
suggest that intensity of statin treatment rather than the degree of LDL reduction or
LDL-C value at 10-month follow-up is more important to regress plaque volumes in
patients with ACS.aging Intravascular - IVUS B101
